PRLD vs. OXLC
Compare and contrast key facts about Prelude Therapeutics Incorporated (PRLD) and Oxford Lane Capital Corp. (OXLC).
Performance
PRLD vs. OXLC - Performance Comparison
Loading graphics...
PRLD vs. OXLC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PRLD Prelude Therapeutics Incorporated | 17.93% | 127.45% | -70.14% | -29.30% | -51.49% | -82.60% | 173.09% |
OXLC Oxford Lane Capital Corp. | -25.18% | -24.38% | 24.58% | 16.52% | -24.15% | 59.91% | 33.83% |
Fundamentals
PRLD:
-$1.47
OXLC:
$2.17
PRLD:
24.77
OXLC:
1.05
PRLD:
$10.50M
OXLC:
$810.81M
PRLD:
$10.08M
OXLC:
$0.00
PRLD:
-$118.57M
OXLC:
$271.23M
Returns By Period
In the year-to-date period, PRLD achieves a 17.93% return, which is significantly higher than OXLC's -25.18% return.
PRLD
- 1D
- 11.40%
- 1M
- 23.91%
- YTD
- 17.93%
- 6M
- 137.50%
- 1Y
- 345.31%
- 3Y*
- -15.66%
- 5Y*
- -39.23%
- 10Y*
- —
OXLC
- 1D
- 3.93%
- 1M
- 22.30%
- YTD
- -25.18%
- 6M
- -29.75%
- 1Y
- -42.43%
- 3Y*
- -8.55%
- 5Y*
- -3.66%
- 10Y*
- 4.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRLD vs. OXLC — Risk / Return Rank
PRLD
OXLC
PRLD vs. OXLC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prelude Therapeutics Incorporated (PRLD) and Oxford Lane Capital Corp. (OXLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRLD | OXLC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.77 | -1.15 | +2.92 |
Sortino ratioReturn per unit of downside risk | 3.37 | -1.60 | +4.97 |
Omega ratioGain probability vs. loss probability | 1.47 | 0.78 | +0.69 |
Calmar ratioReturn relative to maximum drawdown | 4.67 | -0.73 | +5.40 |
Martin ratioReturn relative to average drawdown | 10.24 | -1.42 | +11.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRLD | OXLC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.77 | -1.15 | +2.92 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.32 | -0.14 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.11 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.25 | 0.07 | -0.32 |
Correlation
The correlation between PRLD and OXLC is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
PRLD vs. OXLC - Dividend Comparison
PRLD has not paid dividends to shareholders, while OXLC's dividend yield for the trailing twelve months is around 52.15%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRLD Prelude Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OXLC Oxford Lane Capital Corp. | 52.15% | 35.86% | 20.12% | 18.83% | 17.75% | 10.51% | 22.46% | 19.85% | 16.70% | 17.91% | 22.84% | 24.10% |
Drawdowns
PRLD vs. OXLC - Drawdown Comparison
The maximum PRLD drawdown since its inception was -99.33%, which is greater than OXLC's maximum drawdown of -74.58%. Use the drawdown chart below to compare losses from any high point for PRLD and OXLC.
Loading graphics...
Drawdown Indicators
| PRLD | OXLC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.33% | -74.58% | -24.75% |
Max Drawdown (1Y)Largest decline over 1 year | -70.10% | -57.17% | -12.93% |
Max Drawdown (5Y)Largest decline over 5 years | -98.62% | -57.17% | -41.45% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.58% | — |
Current DrawdownCurrent decline from peak | -96.27% | -46.41% | -49.86% |
Average DrawdownAverage peak-to-trough decline | -84.85% | -13.62% | -71.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.01% | 29.32% | +2.69% |
Volatility
PRLD vs. OXLC - Volatility Comparison
Prelude Therapeutics Incorporated (PRLD) has a higher volatility of 31.39% compared to Oxford Lane Capital Corp. (OXLC) at 11.99%. This indicates that PRLD's price experiences larger fluctuations and is considered to be riskier than OXLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRLD | OXLC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 31.39% | 11.99% | +19.40% |
Volatility (6M)Calculated over the trailing 6-month period | 152.44% | 29.26% | +123.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 196.97% | 37.01% | +159.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 124.27% | 26.32% | +97.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 122.12% | 42.63% | +79.49% |
Financials
PRLD vs. OXLC - Financials Comparison
This section allows you to compare key financial metrics between Prelude Therapeutics Incorporated and Oxford Lane Capital Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities